INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 194 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,478 | +68.9% | 30,878 | +0.8% | 0.01% | +66.7% |
| Q2 2023 | $338,912 | -8.1% | 30,643 | +11.6% | 0.00% | 0.0% |
| Q1 2023 | $368,721 | +5.9% | 27,455 | -2.4% | 0.00% | 0.0% |
| Q4 2022 | $348,055 | +54.0% | 28,137 | +73.4% | 0.00% | +50.0% |
| Q3 2022 | $226,000 | -7.4% | 16,229 | -8.0% | 0.00% | 0.0% |
| Q2 2022 | $244,000 | -50.8% | 17,633 | -42.2% | 0.00% | -60.0% |
| Q1 2022 | $496,000 | -11.0% | 30,515 | -10.8% | 0.01% | -16.7% |
| Q4 2021 | $557,000 | -7.8% | 34,194 | -16.0% | 0.01% | 0.0% |
| Q3 2021 | $604,000 | -30.7% | 40,689 | -6.8% | 0.01% | -25.0% |
| Q2 2021 | $872,000 | -36.8% | 43,680 | -26.9% | 0.01% | -38.5% |
| Q1 2021 | $1,379,000 | -6.3% | 59,735 | +0.2% | 0.01% | -23.5% |
| Q4 2020 | $1,472,000 | -15.6% | 59,614 | +41.7% | 0.02% | -34.6% |
| Q3 2020 | $1,744,000 | -19.0% | 42,057 | -6.4% | 0.03% | -10.3% |
| Q2 2020 | $2,153,000 | -42.5% | 44,933 | -24.5% | 0.03% | -50.0% |
| Q1 2020 | $3,747,000 | -54.1% | 59,511 | -9.8% | 0.06% | -9.4% |
| Q4 2019 | $8,172,000 | +23.6% | 65,948 | +26.1% | 0.06% | +48.8% |
| Q3 2018 | $6,611,000 | +85.6% | 52,318 | +23.2% | 0.04% | +87.0% |
| Q2 2018 | $3,562,000 | +148.2% | 42,454 | +71.7% | 0.02% | +130.0% |
| Q3 2017 | $1,435,000 | -47.5% | 24,720 | +9.5% | 0.01% | -47.4% |
| Q2 2017 | $2,733,000 | +13.2% | 22,573 | +5.8% | 0.02% | +11.8% |
| Q1 2017 | $2,414,000 | -6.8% | 21,342 | -10.5% | 0.02% | -10.5% |
| Q4 2016 | $2,590,000 | -50.1% | 23,842 | -24.4% | 0.02% | -54.8% |
| Q3 2016 | $5,188,000 | +5.2% | 31,521 | -8.8% | 0.04% | -4.5% |
| Q2 2016 | $4,930,000 | +40.3% | 34,551 | +26.3% | 0.04% | +22.2% |
| Q1 2016 | $3,515,000 | -26.6% | 27,364 | -14.6% | 0.04% | -23.4% |
| Q4 2015 | $4,787,000 | – | 32,052 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |